#next gen sequencing

[pathologylab]

Curious about the upcoming developments in molecular field? Mr. Neeraj Gupta, founder and CEO of Genes2Me reveals how new innovations in Pharmacogenomics, Next-Gen sequencing and Home diagnostic test kits are contributing significantly to molecular diagnostics industry.

Read the full article on The Economic Times - https://t2m.io/economictimes

#GeneticTesting #Health #HealthCare #Testing #NGS #Article #sequencing #Screening #Genes2Me #Inovation #CEO #Kits #Diagnostic

[foundationmedicineroche]

Our comprehensive genomic profiling approach leverages next generation sequencing technology to examine regions of the tumour genome that other tests miss

The Foundation Medicine comprehensive genomic profiling approach leverages next generation sequencing (NGS) test technology to examine regions of the tumour genome that other tests miss. It detects both novel and known variants, including the four main classes of genomic alterations - base substitutions, insertions or deletions, copy number alterations and gene rearrangements - in a comprehensive set of cancer-relevant genes, and reports Tumour Mutational Burden (TMB) or blood Tumour Mutational Burden (bTMB), and Microsatellite Instability (MSl). Our clear, in-depth report supports clinical decision-making by providing insights on the patient's genomic profile as well as associated targeted therapies, immunotherapies and relevant clinical trials. When using different Foundation Medicine services across the patient journey, consistency of the reports aids comparison of the results.

[research-news-blog]

Global Bioinformatics Market anticipated to grow at a CAGR of about 20.83% and to reach $22.46 billion by 2023.

the market is driven by drug discovery and development of personalized medicines and clinical diagnostics.

Approximately 34% of bioinformatics market is used for services such as sequencing, data analysis and database management, with 50% used in bioinformatics platform markets. The market for bioinformatics is buoyant, with increasing demand in Asia.

[scienceblogtumbler]

Apple vs Samsung like patent war in the genomics industry

Apple vs Samsung like patent war in the genomics industry

Remember the year 2012, when all we could hear from the smartphone industry was the on-going litigation between Apple and Samsung. Well, after a recent move from Illumina, the world’s largest next generation sequencing instrument provider, we can expect 2016 to be a similar year of litigation in the genomics industry. Except that unlike Apple’s opponent Samsung, who were busy selling smartphones…

View On WordPress

[rzinz]

a nice animation showing one of the next-gen sequencing methods available to the modern molecular biologist- pyrosequencing

naturally, i think this is the coolest thing ever